NYSE American - Nasdaq Real Time Price
USD
IGC Pharma, Inc. (IGC)
0.2000
+0.0110
(+5.82%)
At close: November 6 at 4:00:00 PM EST
0.2039
+0.0039
(+1.95%)
After hours: November 6 at 7:45:01 PM EST
Loading chart for IGC
- Previous Close
0.1890 - Open
0.1910 - Bid 0.1964 x 20000
- Ask 0.2004 x 20000
- Day's Range
0.1806 - 0.2012 - 52 Week Range
0.0800 - 0.4000 - Volume
589,981 - Avg. Volume
765,904 - Market Cap (intraday)
20.677M - Beta (5Y Monthly) 0.55
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
6.00 - Zacks Rating Neutral
Recent News
View MorePerformance Overview
Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
IGC
28.57%
S&P 500 (^GSPC)
7.76%
1-Year Return
IGC
48.72%
S&P 500 (^GSPC)
9.77%
3-Year Return
IGC
33.33%
S&P 500 (^GSPC)
68.96%
5-Year Return
IGC
85.82%
S&P 500 (^GSPC)
57.04%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-50.31%
-
Return on Equity (ttm)
-83.34%
-
Revenue (ttm)
1.11M
-
Net Income Avi to Common (ttm)
-6.45M
-
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
-
Total Cash (mrq)
354k
-
Total Debt/Equity (mrq)
17.64%
-
Levered Free Cash Flow (ttm)
-2.52M
